210 related articles for article (PubMed ID: 36701854)
21. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation.
Zhang JB; Ding ZY; Yang Y; Sun W; Hai F; Sui XN; Li XY; Wang HZ; Wang XT; Zheng JL
Neurol Res; 2010 May; 32(4):353-8. PubMed ID: 20483000
[TBL] [Abstract][Full Text] [Related]
22. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).
Larrue V; von Kummer R R; Müller A; Bluhmki E
Stroke; 2001 Feb; 32(2):438-41. PubMed ID: 11157179
[TBL] [Abstract][Full Text] [Related]
24. Impact of thrombolysis in acute ischaemic stroke without occlusion: an observational comparative study.
Ajili N; Decroix JP; Preda C; Labreuche J; Lopez D; Bejot Y; Michel P; Sévin-Allouet M; Sibon I; Vergnet S; Wang A; Sanda N; Mazighi M; Bourdain F; Lapergue B
Eur J Neurol; 2016 Aug; 23(8):1380-6. PubMed ID: 27222165
[TBL] [Abstract][Full Text] [Related]
25. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of N-acetylcysteine (NAC) as an adjunct to standard treatment in patients with acute ischemic stroke: a randomized controlled pilot trial (NACTLYS).
Komakula S; Bhatia R; Sahib A; Upadhyay A; S LJ; Garg A; Y VV; Pandit AK; Vibha D; Singh MB; Tripathi M; Srivastava MVP
Sci Rep; 2024 Jan; 14(1):1103. PubMed ID: 38212360
[TBL] [Abstract][Full Text] [Related]
27. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
[TBL] [Abstract][Full Text] [Related]
28. Intraarterial Thrombolysis as Rescue Therapy for Large Vessel Occlusions.
Zaidi SF; Castonguay AC; Jumaa MA; Malisch TW; Linfante I; Marden FA; Abraham MG; Chebl AB; Novakovic R; Taqi MA; Nogueira RG; Martin CO; Holloway WE; Mueller-Kronast N; English JD; Dabus G; Bozorgchami H; Xavier A; Rai AT; Froehler MT; Badruddin A; Nguyen TN; Yoo AJ; Shaltoni H; Janardhan V; Chen PR; Britz GW; Kaushal R; Nanda A; Gupta R; Zaidat OO
Stroke; 2019 Apr; 50(4):1003-1006. PubMed ID: 30791829
[TBL] [Abstract][Full Text] [Related]
29. A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.
Joo H; Wang G; George MG
Stroke Vasc Neurol; 2017; 2(2):73-83. PubMed ID: 28736623
[TBL] [Abstract][Full Text] [Related]
30. Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy.
Sanders CB; Knisely K; Rathfoot C; Edrissi C; Nathaniel T
Clin Appl Thromb Hemost; 2022; 28():10760296221116347. PubMed ID: 36278505
[No Abstract] [Full Text] [Related]
31. Peripheral Monocyte Count Predicts Outcomes in Patients with Acute Ischemic Stroke Treated with rtPA Thrombolysis.
Dong X; Nao J; Gao Y
Neurotox Res; 2020 Feb; 37(2):469-477. PubMed ID: 31478125
[TBL] [Abstract][Full Text] [Related]
32. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke.
Lee KY; Kim DI; Kim SH; Lee SI; Chung HW; Shim YW; Kim SM; Heo JH
AJNR Am J Neuroradiol; 2004 Oct; 25(9):1470-5. PubMed ID: 15502123
[TBL] [Abstract][Full Text] [Related]
33. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?
Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S
Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors Associated With Exclusion of Obese Patients Ischemic Stroke With a History of Smoking From Thrombolysis Therapy.
Brewer PC; Ojo DT; Broughton PX; Imeh-Nathaniel A; Imeh-Nathaniel S; Nathaniel TI
Clin Appl Thromb Hemost; 2024; 30():10760296241246264. PubMed ID: 38600881
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study.
Wang X; Li X; Xu Y; Li R; Yang Q; Zhao Y; Wang F; Sheng B; Wang R; Chen S; Wang L; Shen L; Hou X; Cui Y; Wang D; Peng B; Anderson CS; Chen H;
Stroke Vasc Neurol; 2021 Dec; 6(4):603-609. PubMed ID: 33903179
[TBL] [Abstract][Full Text] [Related]
36. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
[TBL] [Abstract][Full Text] [Related]
37. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
[TBL] [Abstract][Full Text] [Related]
38. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR).
Wang Y; Liao X; Zhao X; Wang DZ; Wang C; Nguyen-Huynh MN; Zhou Y; Liu L; Wang X; Liu G; Li H; Wang Y;
Stroke; 2011 Jun; 42(6):1658-64. PubMed ID: 21512182
[TBL] [Abstract][Full Text] [Related]
39. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.
Wang X; You S; Sato S; Yang J; Carcel C; Zheng D; Yoshimura S; Anderson CS; Sandset EC; Robinson T; Chalmers J; Sharma VK
Stroke Vasc Neurol; 2018 Mar; 3(1):28-33. PubMed ID: 29600005
[TBL] [Abstract][Full Text] [Related]
40. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
